4//SEC Filing
Zynerba Pharmaceuticals, Inc. 4
Accession 0001123292-17-000264
CIK 0001621443operating
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:23 PM ET
Size
5.5 KB
Accession
0001123292-17-000264
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2017-01-25+60,000→ 60,000 totalExercise: $18.22Exp: 2027-01-25→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001621443
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:23 PM ET
- Size
- 5.5 KB